ResearcherUniversity of IowaActive in the last 2 years
Bryan G. Allen
Matched on ORCID iD 0000-0002-4893-7105; OpenAlex author ID A5087974114. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 6
- A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Co-author DOI 10.1016/j.redox.2024.103375↗
- Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1680↗
- Design of a compact collimator and 3D imaging system for a scanning beam low-energy intraoperative radiation therapy system for pancreatic cancer. Co-author DOI 10.1109/embc.2017.8037813↗
- Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience… Last author DOI 10.1667/rr14668.1↗
- Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-14-1707↗
- Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-1959↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Garry R. Buettner · 4 shared papers, 2015–2024 · strength 0.31
- Paper A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. DOI 10.1016/j.redox.2024.103375↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Daniel Berg · 3 shared papers, 2017–2024 · strength 0.28
- Paper A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. DOI 10.1016/j.redox.2024.103375↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic C… DOI 10.1667/rr14668.1↗
- John Michael Buatti · 3 shared papers, 2017–2024 · strength 0.28
- Paper A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. DOI 10.1016/j.redox.2024.103375↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic C… DOI 10.1667/rr14668.1↗
- Kellie L. Bodeker · 3 shared papers, 2017–2024 · strength 0.28
- Paper A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. DOI 10.1016/j.redox.2024.103375↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic C… DOI 10.1667/rr14668.1↗
- Joseph J. Cullen · 3 shared papers, 2015–2024 · strength 0.27
- Paper A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. DOI 10.1016/j.redox.2024.103375↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Douglas Robert Spitz · 4 shared papers, 2015–2018 · strength 0.20
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic C… DOI 10.1667/rr14668.1↗
- Paper Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. DOI 10.1158/0008-5472.can-14-1707↗
- Naomi H. Fei · 1 shared paper, 2024 · strength 0.16
- Chandrikha Chandrasekharan · 1 shared paper, 2024 · strength 0.16
- Mandana Kamgar · 1 shared paper, 2024 · strength 0.16
- Joseph Michael Caster · 1 shared paper, 2024 · strength 0.16
- Juan Du · 2 shared papers, 2015–2018 · strength 0.11
- Brianne R. O’Leary · 2 shared papers, 2015–2018 · strength 0.11
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Paper Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-1959↗
- James J. Mezhir · 2 shared papers, 2015 · strength 0.08
- Brennen Neal Wears · 1 shared paper, 2017 · strength 0.08
- Junyi Xia · 1 shared paper, 2017 · strength 0.08
- Matthew S. Alexander · 1 shared paper, 2018 · strength 0.07
- Justin G. Wilkes · 1 shared paper, 2018 · strength 0.07
- Amir Zahra · 1 shared paper, 2017 · strength 0.05
- Jessemae L. Welsh · 1 shared paper, 2015 · strength 0.04
- Prabhat C. Goswami · 1 shared paper, 2015 · strength 0.04
- John A. Cieslak · 1 shared paper, 2015 · strength 0.04
- Zita A. Sibenaller · 1 shared paper, 2015 · strength 0.04
- Susan Tsai · 1 shared paper, 2015 · strength 0.04
- Wendy Cozen · 1 shared paper, 2015 · strength 0.04
- Charles F. Lynch · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.